Coherus Chief: FTC Must Probe Originators’ Anti-Competitive Tactics
• By Aidan Fry
The Federal Trade Commission must act on anti-competitive biologics rebate bundling that is stifling biosimilars uptake, Coherus chief Denny Lanfear insists • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
